Skip to main content
Veterinary Medicines

Effipro duo 134 mg / 40 mg spot-on solution for medium dogs

Authorised
  • Fipronil
  • Pyriproxyfen

Product identification

Medicine name:
EFFIPRO DUO 134 MG/40 MG SPOT-ON SOLUTION FOR MEDIUM DOGS
Effipro duo 134 mg / 40 mg spot-on solution for medium dogs
Active substance:
  • Fipronil
  • Pyriproxyfen
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    134.00
    milligram(s)
    /
    1.00
    Pipette
  • Pyriproxyfen
    40.20
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Box of 4 single-dose pipettes containing 1.34 ml
  • Box of 24 single-dose pipettes containing 1.34 ml
  • Box of 60 single-dose pipettes containing 1.34 ml
  • Box of 1 single-dose pipette containing 1.34 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10988/100/002
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0402/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."